[New antiparasitic drugs].
Bouchaud
O
O
Service des maladies infectieuses et tropicales, hôpital Avicenne, 93009 Bobigny, France. olivier.bouchaud@avc.aphp.fr
Izri
A
A
D015766:Albendazole / Q000494:pharmacology / Q000627:therapeutic use; D000962:Antimalarials / Q000494:pharmacology / Q000627:therapeutic use; D000977:Antiparasitic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use; D003510:Cyclohexanes / Q000494:pharmacology / Q000627:therapeutic use; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007559:Ivermectin / Q000494:pharmacology / Q000627:therapeutic use; D009574:Nitro Compounds; D010767:Phosphorylcholine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D011223:Praziquantel / Q000494:pharmacology / Q000627:therapeutic use; D012717:Sesquiterpenes / Q000494:pharmacology / Q000627:therapeutic use; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use; D000077682:Triclabendazole
D000962:Antimalarials; D000977:Antiparasitic Agents; D001562:Benzimidazoles; D003510:Cyclohexanes; D005231:Fatty Acids, Unsaturated; D009574:Nitro Compounds; D012717:Sesquiterpenes; D013844:Thiazoles; D010767:Phosphorylcholine; D000077682:Triclabendazole; C039128:miltefosine; D011223:Praziquantel; D007559:Ivermectin; C026211:fumagillin; D015766:Albendazole; C041747:nitazoxanide